Detalhe da pesquisa
1.
Antibiotics in early life associate with specific gut microbiota signatures in a prospective longitudinal infant cohort.
Pediatr Res
; 88(3): 438-443, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31954376
2.
Impact of paediatric onset primary sclerosing cholangitis on clinical course and outcome of inflammatory bowel disease: a case-control population-based study in Finland.
Scand J Gastroenterol
; 54(8): 984-990, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402720
3.
Fecal Calprotectin Test Performed at Home: A Prospective Study of Pediatric Patients With Inflammatory Bowel Disease.
J Pediatr Gastroenterol Nutr
; 66(6): 926-931, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29240011
4.
Environmental Risk Factors of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Hepatitis.
J Pediatr Gastroenterol Nutr
; 62(3): 437-42, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26465796
5.
Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.
Am J Gastroenterol
; 110(6): 921-30, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25986361
6.
Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease.
J Crohns Colitis
; 11(3): 321-334, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27609529
7.
Clinical course and prognosis of pediatric-onset primary sclerosing cholangitis.
United European Gastroenterol J
; 4(4): 562-9, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27536366